Prophylaxis for deep venous thrombosis and pulmonary embolism in the surgical patient

Clinical Cornerstone

Volumn 2, Issue 4, 2000, Pages 15-25

  Merli, Geno J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

HUMAN; LUNG EMBOLISM; REVIEW; RISK FACTOR; SURGERY; VEIN THROMBOSIS;

ANTICOAGULANTS; HUMANS; PULMONARY EMBOLISM; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOSIS;

EID: 0033654551     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(00)90010-3     Document Type: Article

References (29)

1. Clagett P, Anderson F, Geerts W, et al. Prevention of venous thromboembolism. Chest. 1998;114: 531S-560S.
2. Virchow R. Neuer fall von todlichen. Emboli der lungenarterie. Arch Pathol Anat. 1856;10:225-228.
3. Nicolaides A, Kakkar V, Field E, et al. Venous stasis and deep vein thrombosis. Br J Surg. 1972;59:713-716.
4. Nicolaides A, Kakkar V, Renney J. Soleal sinuses and stasis. Br J Surg. 1970;57:307.
5. Lindstrom B, Ahlman H, Jonsson O, et al. Influence of anesthesia on blood flow to the calves during surgery. Acta Anaesthesiol Scand. 1984;28: 201-203.
6. Lindstrom B, Ahlman H, Jonsson O, et al. Blood flow in the calves during surgery. Acta Chir Scand. 1977;143:335-339.
7. Sevitt S. Pathology and pathogenesis of deep vein thrombi. In: Bergan I, Yao J, eds. Venous Problems. Chicago, Ill: Year Book Medical Publishing; 1976:257-269.
8. Comerota A, Stewart G, Alburger P, et al. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery. 1989;106:301-309.
9. Stewart G, Alburger P, Stone E, et al. Total hip replacement induces injury to remote veins in a canine model. J Bone Jt Surg. 1983;65A:97-102.
10. 2 in venous valve pockets: its possible bearing on thrombogenesis. Br J Surg. 1981;68:166-170.
11. Merli G. Deep vein thrombosis and pulmonary embolism prophylaxis in the surgical patient, In: Merli G, Weitz H, eds. Medical Care of the Surgical Patient. 2nd ed. Philadelphia, Pa: WB Saunders; 1998.
12. Clagett G, Reisch J. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg. 1988;208:227-239.
13. Leyvraz P, Richard J, Bachmann F, et al. Adjusted versus fixed dose subcutaneous heparin in the prevention of DVT after total hip replacement. N Engl J Med. 1983;309:954-958.
14. Hirsh J, Levine M. Low molecular weight heparin. Blood. 1992;79:1-17.
15. Harris W, Salzman E, Athanasoulis C. Comparison of warfarin, low molecular weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Jt Surg. 1974;56:1555-1562.
16. Francis C, Marder V, Evart C, et al. Two-step warfarin therapy: prevention of postoperative venous thrombosis without excessive bleeding. JAMA. 1983;249:374-378.
17. Amstutz H, Friscia D, Dorey F, et al. Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement. J Bone Jt Surg. 1989;71A:321-326.
18. Caprini J, Scurr J, Hasty J. Role of compression modalities in a prophylactic program for deep vein thrombosis. Semin Thromb Hemost. 1988;14: 77-87.
19. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med. 1998;338: 409-415.
20. Nurmohamed M, van Riel A, Henkens C, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost. 1996;75:233-238.
21. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339:80-85.
22. Lumpkin M. FDA Alert: FDA Public Advisory. Anesthesiology. 1998;88:27A-28A.
23. Horlocker T, Heit J. Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg. 1997;85:874-885.
24. American Society of Regional Anesthesia Consensus Statements on Neuraxial Anesthesia and Anticoagulation. Developed from the American Society of Regional Anesthesia Consensus Conference; May 2-3, 1998; Chicago, Ill.
25. Planes A, Vochelle N, Darmon J, et al. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of enoxaparin versus placebo. Lancet. 1996;348:224-228.
26. Bergqvist D, Benoni G, Bjurgell O, et al. Low molecular weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med. 1996;335:696-700.
27. Dahl O, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery: results of a double blind, prospective, randomized, placebo controlled study with dalteparin (Fragmin). Thromb Haemost. 1997;77:26-31.
28. Spandorfer J, Lynch S, Weitz H, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol. 1999; 84:478-480.
29. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;336:1506-1511.